Urological Chronic Pelvic Pain Syndrome improves when underlying neuromuscular dysfunction is addressed in an outpatient, multimodal treatment protocol

Background: Urological chronic pelvic pain syndrome (UCPPS) combines two of the most widespread chronic urological pain disorders: interstitial cystitis (IC)/bladder pain syndrome (BPS) and chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS). This manuscript aims to assess the effectiveness of an outpatient, multimodal treatment protocol for men with UCPPS. Methods: A retrospective study of 58 male patients was done on an institutional review board approved protocol consisting of pelvic floor physical therapy (PFPT) in concomitance with the pelvic floor muscles receiving ultrasound guided trigger point injections and peripheral nerve blocks weekly for six weeks. Patients rated their levels of pelvic pain, performance, and quality of life via Visual Analogue Scale (VAS), Functional Pelvic Pain Scale (FPPS), and NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) at their new patient consult and 3-month follow up. Results: Initial average VAS was 6.24 ± 2.26 and average VAS after treatment reduced to 4.25 ± 2.8. Initial average FPPS score was 9.21 ± 5.24. Final average FPPS reduced to 7.28 ± 5.03. Initial average total NIH-CPSI score was 24.55 ± 6.43 and after treatment reduced to 18.36 ± 7.62. Initial average NIH-CPSI pain, urinary symptoms, and quality of life sub scores were 11.28 ± 3.46, 3.41 ± 3.31, and 9.86 ± 2.05, respectively. After treatment, they decreased to 8.34 ± 4.14, 2.47 ± 2.45, and 7.55 ± 2.74. Differences in pre and post treatment outcomes were statistically significant. Conclusions: This shows the protocol was successful at improving pain and performance in male UCPPS patients. This supports the validity of a multimodal treatment protocol given patients failed to improve after a full course of PFPT by itself. However, they improved once PFPT was combined with other treatment modalities, alleviating the underlying neuropathic and myofascial pain seen in UCPPS.

Chronic pelvic pain syndrome; Chronic prostatitis; Pelvic floor muscle dysfunction; Male pelvic pain; Multimodal therapy; Psychometrics; Questionnaire

[1] Clemens JQ, Mullins C, Ackerman AL, Bavendam T, van Bokhoven A, Ellingson BM, et al. Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network. Nature Reviews Urology. 2019; 16: 187–200.

[2] Smith C. Male chronic pelvic pain: an update. Indian Journal of Urology. 2016; 32: 34.

[3] Nickel J C, Tripp D, Gordon A, et al. Update on urologic pelvic pain syndromes: highlights from the 2010 international chronic pelvic pain symposium and workshop, august 29, 2010, kingston, ontario, Canada. Reviews in urology. 2011, 13: 39–49.

[4] Nickel JC, Alexander RB, Anderson R, Berger R, Comiter CV, Datta NS, et al. Category III chronic prostatitis/chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies. Current Urology Reports. 2009; 9: 320–327.

[5] Malykhina AP. Neural mechanisms of pelvic organ cross-sensitization. Neuroscience. 2008; 149: 660–672.

[6] Woolf CJ. Central sensitization: Implications for the diagnosis and treatment of pain. Pain. 2011; 152: S2–S15.

[7] Franco JV, Turk T, Jung JH, et al. Non-pharmacological inter-ventions for treating chronic prostatitis/chronic pelvic pain syn-drome. Cochrane systematic review. 2019;124: 197–208.

[8] Shrikhande A, Ullger C, Seko K, Patil S, Natarajan J, Tailor Y, et al. A physiatrist’s understanding and application of the cur-rent literature on chronic pelvic pain: a narrative review. PAIN Reports. 2021; 6: e949.

[9] Yang CC, Miller JL, Omidpanah A, Krieger JN. Physical Exam-ination for Men and Women with Urologic Chronic Pelvic Pain Syndrome: a MAPP (Multidisciplinary Approach to the Study of Chronic Pelvic Pain) Network Study. Urology. 2018; 116: 23–29.

[10] Shoskes DA, Prots D, Karns J, Horhn J, Shoskes AC. Greater en-dothelial dysfunction and arterial stiffness in men with chronic prostatitis/chronic pelvic pain syndrome–a possible link to car-diovascular disease. The Journal of Urology. 2011; 186: 907–910.

[11] Magri V, Boltri M, Cai T, Colombo R, Cuzzocrea S, De Viss-chere P, et al. Multidisciplinary approach to prostatitis. Archivio Italiano di Urologia e Andrologia. 2018; 90: 227–248.

[12] Natarajan J, Ahmed T, Patil S, Mamsaang M, Kapadia R, Tai-lor Y, et al. Pain and functionality improved when underlying neuromuscular dysfunction addressed in chronic pelvic pain pa-tients. Neurourology and Urodynamics. 2021; 40: 1609–1615.

[13] Bonder JH, Chi M, Rispoli L. Myofascial Pelvic Pain and Re-lated Disorders. Physical Medicine and Rehabilitation Clinics of North America. 2018; 28: 501–515.

[14] Marcus NJ, Shrikhande AA, McCarberg B, Gracely E. A prelim-inary study to determine if a muscle pain protocol can produce long-term relief in chronic back pain patients. Pain Medicine. 2014; 14: 1212–1221.

[15] Hetrick DC, Ciol MA, Rothman I, Turner JA, Frest M, Berger RE. Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case-control study. The Journal of Urology. 2003; 170: 828–831.

[16] Prendergast SA, Weiss JM. Screening for musculoskeletal causes of pelvic pain. Clinical Obstetrics and Gynecology. 2003; 46: 773–782.

[17] McDonald DM, Bowden JJ, Baluk P, Bunnett NW. Neurogenic inflammation. a model for studying efferent actions of sensory nerves. Advances in Experimental Medicine and Biology. 1997; 410: 453–462.

[18] Yanagi H, Sankawa H, Saito H, Iikura Y. Effect of lidocaine on histamine release and Ca2+ mobilization from mast cells and ba-sophils. Acta Anaesthesiologica Scandinavica. 1996; 40: 1138–1144.

[19] Staud R, Nagel S, Robinson ME, Price DD. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain. 2009; 145: 96–104.

[20] Bharucha AE, Lee TH. Anorectal and Pelvic Pain. Mayo Clinic Proceedings. 2016; 91: 1471–1486.

[21] Labat J, Riant T, Robert R, Amarenco G, Lefaucheur J, Rigaud J. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourology and Urodynamics. 2008; 27: 306–310.

[22] Kaur J, Singh P, Pudendal Nerve Entrapment Syndrome. Trea-sure Island: FL. 2021.

[23] Ustinova EE, Fraser MO, Pezzone MA. Cross-talk and sensitiza-tion of bladder afferent nerves. Neurourology and Urodynamics. 2010; 29: 77–81.

[24] Christianson JA, Liang R, Ustinova EE, Davis BM, Fraser MO, Pezzone MA. Convergence of bladder and colon sensory in-nervation occurs at the primary afferent level. Pain. 2007; 128: 235–243.

[25] Li H, Kang D. Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis. World Journal of Urology. 2016; 34: 1009–1017.

[26] Clemens JQ, Nadler RB, Schaeffer AJ, Belani J, Albaugh J, Bushman W. Biofeedback, pelvic floor re-education, and blad-der training for male chronic pelvic pain syndrome. Urology. 2000; 56: 951–955.